Manuel S. Rodriguez
ITAV CNRS, Toulouse
Manuel S. Rodriguez obtained his first degrees from the National Autonomous University of Mexico (UNAM). After his Ph.D. in Microbiology at Paris 7 University/Pasteur Institute, most of his carrier has continued in Europe in distinct research centres including the Centre for Biomolecular Sciences of the University of St. Andrews (UK), Jacques Monod Institute-CNRS (France), CIC bioGUNE and Inbiomed (Spain). He is currently based at the ITAV-IPBS (France).
He is founder member of the European Network INPROTEOLYS and co-coordinator of the ITN–Marie Curie networks UPStream and UbiCODE, both dedicated to study of the ubiquitin-proteasome system.
Manuel S. Rodriguez obtained his first degrees from the National Autonomous University of Mexico (UNAM). After his Ph.D. in Microbiology at Paris 7 University/Pasteur Institute, most of his carrier has continued in Europe in distinct research centres including the Centre for Biomolecular Sciences of the University of St. Andrews (UK), Jacques Monod Institute-CNRS (France), CIC bioGUNE and Inbiomed (Spain). He is currently based at the ITAV-IPBS (France).
He is founder member of the European Network INPROTEOLYS and co-coordinator of the ITN–Marie Curie networks UPStream and UbiCODE, both dedicated to study of the ubiquitin-proteasome system.
Dimitris Xirodimas
CRBM CNRS, Montpellier
Dimitris Xirodimas was educated in Athens, Greece, before moving to Scotland in 1991 for his undergraduate studies at the University of Dundee. After graduation with a 1st class Honours Biochemistry degree in 1995, he joined Prof. Sir David Lane’s laboratory as a PhD student and then as post-doctoral research assistant. His studies were focussed on the role of ubiquitin and ubiquitin-like molecules such as SUMO and NEDD8 in controlling the function of the p53 tumour suppressor. In 2004 he moved to the University of St-Andrews in Prof. Ronald Hay’s laboratory, as a post-doctoral research fellow and applied proteomic approaches for the identification of novel targets for the ubiquitin-like molecule NEDD8. In 2005, he established his own research team in the Wellcome Trust Centre for Gene Regulation and Expression at the University of Dundee through a Career Development Research Fellowship from the Association of International Cancer Research. In 2011 he established his laboratory at the CRBM-CNRS Institute in Montpellier and his research interest is on the role of ubiquitin and ubiquitin-like molecules in the cellular response to stress.
Dimitris Xirodimas was educated in Athens, Greece, before moving to Scotland in 1991 for his undergraduate studies at the University of Dundee. After graduation with a 1st class Honours Biochemistry degree in 1995, he joined Prof. Sir David Lane’s laboratory as a PhD student and then as post-doctoral research assistant. His studies were focussed on the role of ubiquitin and ubiquitin-like molecules such as SUMO and NEDD8 in controlling the function of the p53 tumour suppressor. In 2004 he moved to the University of St-Andrews in Prof. Ronald Hay’s laboratory, as a post-doctoral research fellow and applied proteomic approaches for the identification of novel targets for the ubiquitin-like molecule NEDD8. In 2005, he established his own research team in the Wellcome Trust Centre for Gene Regulation and Expression at the University of Dundee through a Career Development Research Fellowship from the Association of International Cancer Research. In 2011 he established his laboratory at the CRBM-CNRS Institute in Montpellier and his research interest is on the role of ubiquitin and ubiquitin-like molecules in the cellular response to stress.
Gaëlle Legube
LBCMCP CNRS, Toulouse
After a PhD in the group of Didier Trouche in Toulouse on the regulation of histone acetyltransferase, Gaëlle Legube joined the group of Asifa Akhtar at EMBL in Germany to work on dosage compensation in Drosophila. She obtained a permanent position at the CNRS in France and started her own group at the CBI in Toulouse in 2011. Her lab investigates the function of chromatin during DNA Double Strand Break Repair mostly using genome wide approaches.
After a PhD in the group of Didier Trouche in Toulouse on the regulation of histone acetyltransferase, Gaëlle Legube joined the group of Asifa Akhtar at EMBL in Germany to work on dosage compensation in Drosophila. She obtained a permanent position at the CNRS in France and started her own group at the CBI in Toulouse in 2011. Her lab investigates the function of chromatin during DNA Double Strand Break Repair mostly using genome wide approaches.
Guillaume Bossis
IGMM CNRS, Montpellier
Guillaume Bossis started to get interested in the Ubiquitin-like field during his PhD, working at the IGMM (Montpellier) on both the Ubiquitination and SUMOylation of AP-1 transcription factors. He then joined Pr Frauke Melchior in Munich for a post-doc where he was interested in the regulation of SUMOylation by oxidative stress. He is currently working at the IGMM in Montpellier on the role of UbL in Acute Myeloid Leukemias
Guillaume Bossis started to get interested in the Ubiquitin-like field during his PhD, working at the IGMM (Montpellier) on both the Ubiquitination and SUMOylation of AP-1 transcription factors. He then joined Pr Frauke Melchior in Munich for a post-doc where he was interested in the regulation of SUMOylation by oxidative stress. He is currently working at the IGMM in Montpellier on the role of UbL in Acute Myeloid Leukemias
Stéphane Manenti
CRCT INSERM, Toulouse
Stéphane Manenti obtained his PhD in Biophysics at the Institut Jacques Monod, in Paris, before to join the Biozentrum of Basel (Switzerland) where he investigated protein kinase C substrates phosphorylation by mass spectrometry, during his post-doctoral work. He then obtained a permanent position at the CNRS in Toulouse, to work on cell cycle and cell signaling regulations in different models. He is now (since 2011) team leader at the Cancer Research Center of Toulouse, working on cell signaling, cell cycle and autophagy pathways in myeloid malignancies.
Stéphane Manenti obtained his PhD in Biophysics at the Institut Jacques Monod, in Paris, before to join the Biozentrum of Basel (Switzerland) where he investigated protein kinase C substrates phosphorylation by mass spectrometry, during his post-doctoral work. He then obtained a permanent position at the CNRS in Toulouse, to work on cell cycle and cell signaling regulations in different models. He is now (since 2011) team leader at the Cancer Research Center of Toulouse, working on cell signaling, cell cycle and autophagy pathways in myeloid malignancies.
Olivier Coux
CRBM CNRS, Toulouse
After his PhD at the Institut Jacques Monod In Paris, Olivier Coux joined the group of Alfred L. Goldberg at Harvard Medical School (Boston, USA) to study the ubiquitin-proteasome system and particularly the 26S proteasome. He came back to France at the end of 1997 and created his team at the CRBM. The main focus of his lab is now on the study on an intriguing nuclear regulator of the proteasome, PA28gamma.
After his PhD at the Institut Jacques Monod In Paris, Olivier Coux joined the group of Alfred L. Goldberg at Harvard Medical School (Boston, USA) to study the ubiquitin-proteasome system and particularly the 26S proteasome. He came back to France at the end of 1997 and created his team at the CRBM. The main focus of his lab is now on the study on an intriguing nuclear regulator of the proteasome, PA28gamma.
Pierre G. Lutz
IPBS CNRS, Toulouse
Pierre G. Lutz, Ph.D., is a group leader in the Cancer Biology Department at the Institute of Pharmacology and Structural Biology in Toulouse, France. His lab is mainly focusing on normal and leukemic hematopoiesis. He became interested in the ubiquitin-proteasome field following the cloning of the ASB2 gene that encodes subunits of Cullin 5 Ring Ligases. His lab aims to understand the roles of ASB2 proteins in cell differentiation and their dysfunction in diseases. Indeed, work in his lab identified the ASB2α isoform as a regulator of cytoskeleton organization and cell motility through the degradation of the actin-binding protein filamins.
Pierre G. Lutz, Ph.D., is a group leader in the Cancer Biology Department at the Institute of Pharmacology and Structural Biology in Toulouse, France. His lab is mainly focusing on normal and leukemic hematopoiesis. He became interested in the ubiquitin-proteasome field following the cloning of the ASB2 gene that encodes subunits of Cullin 5 Ring Ligases. His lab aims to understand the roles of ASB2 proteins in cell differentiation and their dysfunction in diseases. Indeed, work in his lab identified the ASB2α isoform as a regulator of cytoskeleton organization and cell motility through the degradation of the actin-binding protein filamins.